| NCT ID | NCT01256398 |
| Title | Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | no |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies |
Cyclophosphamide + Fludarabine Vincristine + Methotrexate + Mercaptopurine |
| Age Groups: | adult |